Court backs Pfizer - Cheaper generics withstand lawsuit

Pfizer Inc. and other drug companies have the right to sell unbranded versions of their own drugs even if they undercut sales of generic competitors, a U.S. appeals court ruled. The U.S. Federal Trade Commission, at the urging of three U.S. senators, is looking into whether "authorized generics" are anticompetitive. Under federal law, the first generic-drug maker to challenge patents on a drug wins six months of exclusive marketing rights. Teva argued that Pfizer sought to thwart competition by undermining that incentive


Court backs Pfizer

BioBOOM Op/ed: Does this mean there's your "V" blue pill and soon a no-name white one in a white box for less? Heck we thought resale low prices or what one could call "brand neutral" just was a Canada or Mexico road trip.

No comments:

Blog Archive